Business UpdateJul 21, 2026, 07:31 AM
Rezolute to Participate in BTIG Virtual Biotechnology Conference
AI Summary
Rezolute, Inc., a late-stage ultra-rare disease company, announced that its management will participate in the BTIG Virtual Biotechnology Conference from July 28-29, 2026. During the conference, management will be available for one-on-one investor meetings. Interested investors are advised to contact their BTIG representatives to arrange a meeting.
Key Highlights
- Rezolute management to participate in BTIG Virtual Biotechnology Conference.
- Conference scheduled for July 28-29, 2026.
- Management will hold one-on-one investor meetings.
- Investors can schedule meetings through their BTIG representative.
Price Impact
More from RZLT